The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary immunoglobulin A (IgA) nephropathy, maker Novartis announced late on Wednesday.

The FDA has granted accelerated approval to Vanrafia to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression.

Astrasentan becomes the first and only endothelin A receptor antagonist to focus on proteinuria reduction in primary ...

Edgar Lerma, MD, provides insights into the pathophysiology of IgA nephropathy (IgAN) and the therapeutic promise of ...

Often skin changes are harmless and clear up on their own, but others can be warning signs of something more serious ...

This is their second meeting within a month. Iga Swiatek and Mirra Andreeva are on a collision course once again but this time, under the California sun in the Indian Wells Open 2025 semifinals.

Poland's Iga Swiatek is aiming to win a third title at Indian Wells in four years Defending champion Iga Swiatek cruised past Zheng Qinwen to set up an Indian Wells semi-final against teenager ...

Iga Swiatek has been a hallmark of consistency in women's tennis over the last few years, and all her winning is starting to pay dividends. With a dominant 6-1, 6-1 win over Karolina Muchova at ...

Over the course of her first three matches at the BNP Paribas Open, Iga Swiatek has done that six times. Her opponents have combined to do it once. The Pole has won three 14-game matches at Indian ...

Italian Prime Minister Giorgia Meloni suggested on March 6 that NATO could extend Article 5 protections to Ukraine without granting Kyiv membership in the alliance. The collective defense principle ...